14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of IKNA
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Ikena Oncology, Inc. stock upgraded from Sell Candidate to Hold/Accumulate after Thursday trading session.
(Updated on May 02, 2024)

Hold candidate since May 02, 2024 PDF

The Ikena Oncology, Inc. stock price gained 1.54% on the last trading day (Thursday, 2nd May 2024), rising from $1.30 to $1.32. During the last trading day the stock fluctuated 4.69% from a day low at $1.28 to a day high of $1.34. The price has been going up and down for this period, and there has been a 4.76% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 187 thousand more shares were traded than the day before. In total, 315 thousand shares were bought and sold for approximately $416.14 thousand.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -8.05% during the next 3 months and, with a 90% probability hold a price between $1.12 and $1.40 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

IKNA Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, April 17, 2024, and so far it has risen 6.45%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Ikena Oncology, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Ikena Oncology, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $1.37. On a fall, the stock will find some support from the short-term average at $1.31. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss for Ikena Oncology, Inc. stock

Ikena Oncology, Inc. finds support from accumulated volume at $1.30 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0600 between high and low, or 4.69%. For the last week, the stock has had daily average volatility of 4.22%.

Our recommended stop-loss: $1.26 (-4.86%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 11 days ago.)

Trading Expectations (IKNA) For The Upcoming Trading Day Of Friday 3rd

For the upcoming trading day on Friday, 3rd we expect Ikena Oncology, Inc. to open at $1.31, and during the day (based on 14 day Average True Range), to move between $1.23 and $1.41, which gives a possible trading interval of +/-$0.0894 (+/-6.77%) up or down from last closing price. If Ikena Oncology, Inc. takes out the full calculated possible swing range there will be an estimated 13.54% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.33 (0.76%) than the support at $1.30 (1.52%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Ikena Oncology, Inc. stock A Buy?

Ikena Oncology, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: 0.457 Hold/Accumulate Upgraded

Predicted Opening Price for Ikena Oncology, Inc. of Friday, May 3, 2024

Fair opening price May 3, 2024 Current price
$1.31 ( 0.505%) $1.32

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for IKNA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.37 4.04 %
R2 1.35 2.30 %
R1 1.34 1.23 %
Current price: 1.32
Support S1 1.29 -2.24 %
S2 1.28 -3.31 %
S3 1.25 -5.05 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.52 15.15 %
R2 1.46 10.61 %
R1 1.33 0.758 %
Current price 1.32
Support S1 1.30 -1.52%
S2 1.28 -3.03%
S3 1.27 -3.79%

FAQ

What is the symbol for Ikena Oncology, Inc. Stock and on which exchange is it traded?
The symbol for Ikena Oncology, Inc. is IKNA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Ikena Oncology, Inc. Stock?
Ikena Oncology, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy Ikena Oncology, Inc. Stock?
Ikena Oncology, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Ikena Oncology, Inc. Stock.

What's the current price of Ikena Oncology, Inc. Stock?
As of the end of day on the May 02, 2024, the price of an Ikena Oncology, Inc. (IKNA) share was $1.32.

What is the 52-week high and low for Ikena Oncology, Inc. Stock?
The 52-week high for Ikena Oncology, Inc. Stock is $7.64 and the 52-week low is $1.02.

What is the market capitalization of Ikena Oncology, Inc. Stock?
As of the May 02, 2024, the market capitalization of Ikena Oncology, Inc. is 63.701M.

When is the next earnings date for Ikena Oncology, Inc.?
The upcoming earnings date for Ikena Oncology, Inc. is May 20, 2024.
Click to get the best stock tips daily for free!

About Ikena Oncology, Inc.

Ikena Oncology. Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. It is also developing a small molecule inhibitor program against ERK5 in the RAS signaling pathway; IK-1... IKNA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT